Hepatocyte growth factor (HGF), via its c-met receptor, is an important regulator of kidney development, growth, and function and plays a central role in regulating the renal repair processes following injury. Studies from this and other laboratories indicate that renal c-met induction is a crucial event increasing HGF action and targeting it specifically to renal epithelial cells. Since c-met induction occurs primarily at the transcriptional level, induced c-met transcription is an important mechanism leading to tubular repair and regeneration. Therefore, the overall goals of this proposal are to examine the molecular mechanism(s) governing c-met regulation and to investigate the biological effects of c-met/HGF in kidney cells. This will be accomplished by applying molecular and cellular biologic techniques in three Specific Aims.
In Aim 1, the c-met gene will be cloned and its structural organization and promoter region will be fully characterized.
In Aim 2, the molecular mechanism(s) underlying ligand induced c-met expression will be characterized by transfecting promoter-CAT reporter gene constructs into renal epithelial cells and exposing them to HGF. Novel elements dictating c-met expression will also be identified and further analyzed by DNA-protein interaction and site-directed mutagenesis studies.
In Aim 3, the biological effects of HGF/c-met on renal epithelial cell injury and repair will be investigated by examining the role of HGF in protecting renal epithelial cell from apoptosis. These studies will provide novel information on the gene structure of this unique receptor as well as important insights into the transcriptional regulation of c-met expression and its function in normal and diseased kidneys. Ultimately, these studies may suggest novel strategies to alter the course of human renal disease by regulating the HGF/c-met axis, and thereby, modifying cell repair and growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054922-05
Application #
6381383
Study Section
General Medicine B Study Section (GMB)
Program Officer
Scherbenske, M James
Project Start
1998-06-01
Project End
2003-05-31
Budget Start
2001-06-01
Budget End
2002-05-31
Support Year
5
Fiscal Year
2001
Total Cost
$153,674
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Giannopoulou, Myrto; Dai, Chunsun; Tan, Xiaoyue et al. (2008) Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling. Am J Pathol 173:30-41
Tan, Ruoyun; Zhang, Xianghong; Yang, Junwei et al. (2007) Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor. J Am Soc Nephrol 18:2340-9
Li, Yingjian; Yang, Junwei; Luo, Jian-Hua et al. (2007) Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J Am Soc Nephrol 18:449-60
Tan, Ruoyun; Zhang, Jinglan; Tan, Xiaoyue et al. (2006) Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol 17:2781-91
Hu, Kebin; Yang, Junwei; Tanaka, Sakae et al. (2006) Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J Biol Chem 281:2120-7
Giannopoulou, Myrto; Iszkula, Steven C; Dai, Chunsun et al. (2006) Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-gamma inhibition of TGF-beta1 action. Am J Physiol Renal Physiol 290:F1234-40
Liu, Youhua (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69:213-7
Li, Yingjian; Wen, Xiaoyan; Spataro, Bradley C et al. (2006) hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. J Am Soc Nephrol 17:54-65
Tan, Xiaoyue; Li, Yingjian; Liu, Youhua (2006) Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 17:3382-93
Xia, Jing-Lin; Dai, Chunsun; Michalopoulos, George K et al. (2006) Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168:1500-12

Showing the most recent 10 out of 38 publications